Kazumi Hayashi

1.4k total citations
33 papers, 958 citations indexed

About

Kazumi Hayashi is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Kazumi Hayashi has authored 33 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Kazumi Hayashi's work include Immunotherapy and Immune Responses (6 papers), Microbial Metabolism and Applications (3 papers) and HER2/EGFR in Cancer Research (3 papers). Kazumi Hayashi is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Microbial Metabolism and Applications (3 papers) and HER2/EGFR in Cancer Research (3 papers). Kazumi Hayashi collaborates with scholars based in Japan and China. Kazumi Hayashi's co-authors include Yumiko Moritani, Tomihisa Kawasaki, Tetsu Saito, Masatoshi Taniguchi, Jun Takasaki, Masato Kobori, Sadamu Homma, Yuko Kamata, Koji Nagai and Masaki Ito and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Neurology.

In The Last Decade

Kazumi Hayashi

30 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazumi Hayashi Japan 14 521 193 172 157 85 33 958
Claudio Raimondi United Kingdom 18 841 1.6× 233 1.2× 106 0.6× 140 0.9× 54 0.6× 27 1.2k
Laura Asnaghi United States 20 924 1.8× 230 1.2× 142 0.8× 65 0.4× 78 0.9× 38 1.4k
Mien Van Hoang United States 15 526 1.0× 136 0.7× 170 1.0× 160 1.0× 82 1.0× 19 841
Vittoria Matafora Italy 21 879 1.7× 151 0.8× 135 0.8× 120 0.8× 99 1.2× 40 1.3k
Xiu-Rong Ren United States 17 1.2k 2.2× 259 1.3× 123 0.7× 316 2.0× 59 0.7× 20 1.5k
Katie O’Callaghan United States 11 480 0.9× 153 0.8× 87 0.5× 143 0.9× 38 0.4× 19 904
Eun‐Young Shin South Korea 18 614 1.2× 129 0.7× 91 0.5× 114 0.7× 104 1.2× 47 991
Michele Pallaoro Italy 10 1.2k 2.3× 319 1.7× 246 1.4× 108 0.7× 108 1.3× 12 1.5k
Takayuki Shiratsuchi Japan 17 591 1.1× 185 1.0× 209 1.2× 154 1.0× 84 1.0× 22 1.0k
Takako Ohsawa Japan 14 444 0.9× 131 0.7× 117 0.7× 189 1.2× 170 2.0× 34 1.1k

Countries citing papers authored by Kazumi Hayashi

Since Specialization
Citations

This map shows the geographic impact of Kazumi Hayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazumi Hayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazumi Hayashi more than expected).

Fields of papers citing papers by Kazumi Hayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazumi Hayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazumi Hayashi. The network helps show where Kazumi Hayashi may publish in the future.

Co-authorship network of co-authors of Kazumi Hayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Kazumi Hayashi. A scholar is included among the top collaborators of Kazumi Hayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazumi Hayashi. Kazumi Hayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagasaki, Eijiro, Miho Tamura, Kazumi Hayashi, et al.. (2021). Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report. Breast Cancer. 28(5). 1051–1061. 9 indexed citations
2.
Kondo, Mitsuhiro, et al.. (2020). Therapeutic effects of interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 on diabetic nephropathy in type 2 diabetic mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 393(7). 1197–1209. 9 indexed citations
3.
4.
Kamata, Yuko, Yukiko Sagawa, Kazumi Hayashi, et al.. (2018). Claudin 7 as a possible novel molecular target for the treatment of pancreatic cancer. Pancreatology. 19(1). 88–96. 11 indexed citations
5.
Hayashi, Kazumi, Eijiro Nagasaki, Koji Nakada, et al.. (2017). Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2. Journal of Infection and Chemotherapy. 24(4). 298–301. 4 indexed citations
6.
Akasaki, Yasuharu, Tetsuro Kikuchi, Sadamu Homma, et al.. (2016). Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma. Cancer Immunology Immunotherapy. 65(12). 1499–1509. 52 indexed citations
7.
Kan, Shin, Shigeo Koido, Masato Okamoto, et al.. (2015). Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine. Oncology Reports. 34(1). 504–510. 25 indexed citations
8.
Komita, Hideo, Shigeo Koido, Kazumi Hayashi, et al.. (2015). Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors. Oncology Reports. 34(4). 2099–2105. 42 indexed citations
9.
10.
Koido, Shigeo, Masaki Ito, Yukiko Sagawa, et al.. (2014). Vaccination with vascular progenitor cells derived from induced pluripotent stem cells elicits antitumor immunity targeting vascular and tumor cells. Cancer Immunology Immunotherapy. 63(5). 459–468. 6 indexed citations
11.
Ito, Masaki, Kazumi Hayashi, Tamiko Minamisawa, et al.. (2014). Combinatorial Contextualization of Peptidic Epitopes for Enhanced Cellular Immunity. PLoS ONE. 9(10). e110425–e110425. 4 indexed citations
12.
Hayashi, Kazumi. (2008). Kidney disease: potential of anti-inflammatory approaches for drug therapy. Folia Pharmacologica Japonica. 132(2). 89–95.
13.
Araya, Juan Carlos, Yoshinori Kawabata, Kazunari Kaneko, et al.. (2007). Allergic inflammatory reaction is involved in necrosis of human pulmonary dirofilariasis. Histopathology. 51(4). 484–490. 7 indexed citations
14.
Kawasaki, Tomihisa, Masatoshi Taniguchi, Yumiko Moritani, et al.. (2006). Biological properties of a specific Gαq/11 inhibitor, YM‐254890, on platelet functions and thrombus formation under high‐shear stress. British Journal of Pharmacology. 148(1). 61–69. 49 indexed citations
15.
Taniguchi, Masatoshi, Yumiko Moritani, Takeshi Shigenaga, et al.. (2005). Pharmacological properties of YM-254890, a specific Gαq/11 inhibitor, on thrombosis and neointima formation in mice. Thrombosis and Haemostasis. 94(7). 184–192. 37 indexed citations
16.
Iwatsuki, Yoshiyuki, Kazumi Hayashi, Yumiko Moritani, et al.. (2004). Combined effects of a factor Xa inhibitor YM466 and a GPIIb/IIIa antagonist YM128 on thrombosis and neointima formation in mice. Thrombosis and Haemostasis. 92(12). 1221–1228. 12 indexed citations
17.
Takasaki, Jun, Tetsu Saito, Masatoshi Taniguchi, et al.. (2004). A Novel Gαq/11-selective Inhibitor. Journal of Biological Chemistry. 279(46). 47438–47445. 329 indexed citations
18.
Taniguchi, Masatoshi, Ken‐ichi Suzumura, Koji Nagai, et al.. (2004). YM-254890 analogues, novel cyclic depsipeptides with Gαq/11 inhibitory activity from Chromobacterium sp. QS3666. Bioorganic & Medicinal Chemistry. 12(12). 3125–3133. 47 indexed citations
19.
Kumagai, Keigo, I Ohno, Kazumi Hayashi, et al.. (2002). The involvement of matrix metalloproteinases in basement membrane injury in a murine model of acute allergic airway inflammation. Clinical & Experimental Allergy. 32(10). 1527–1534. 22 indexed citations
20.
Tominaga, T., et al.. (1984). [Effects of 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on patients with advanced and recurrent breast cancer].. PubMed. 11(8). 1669–74. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudio Raimondi Breakdown of academic impact, for papers by Laura Asnaghi Breakdown of academic impact, for papers by Mien Van Hoang Breakdown of academic impact, for papers by Vittoria Matafora Breakdown of academic impact, for papers by Xiu-Rong Ren Breakdown of academic impact, for papers by Katie O’Callaghan Breakdown of academic impact, for papers by Eun‐Young Shin Breakdown of academic impact, for papers by Michele Pallaoro Breakdown of academic impact, for papers by Takayuki Shiratsuchi Breakdown of academic impact, for papers by Takako Ohsawa
Rankless by CCL
2026